![](/img/cover-not-exists.png)
Updated results of the assessment of the role of her-2 overexpression as a predictive factor to neoadjuvant, anthracycline-containing chemotherapy in locally-advanced breast cancer (LABC)
B. Bauer-Kosinska, Lemanska, D. Larecka, R. Sienkiewicz, T. PienkowskiVolume:
4
Year:
2006
Language:
english
DOI:
10.1016/s1359-6349(06)80385-x
File:
PDF, 139 KB
english, 2006